Surprise! The teams at Two Onc Docs and The Fellow on Call are teaming up for his special series! Each episode will focus on a single abstract, poster, or oral presentation from ASCO 2023, and will feature a quick review of any guidelines and management pointers relevant to the disease state under study, followed by an overview of the study design and findings, and finally a discussion of the implications of the research on clinical practice.We expect to release episodes on June 12, 14, 19, 21, and 26. Episodes will be released alternating between our two podcasts, so make sure you’re subscribed to both!Follow Two Onc Docs on Twitter: www.twitter.com/twooncdocsSubscribe to Two Onc Docs on Apple Podcasts: https://podcasts.apple.com/us/podcast/two-onc-docs/id1616541733 Follow The Fellow on Call on Twitter: www.twitter.com/thefellowoncall Subscribe to The Fellow on Call on Apple Podcasts: https://podcasts.apple.com/us/podcast/the-fellow-on-call-the-heme-onc-podcast/id1602921628 Subscribe to The Fellow on Call on Spotify: https://open.spotify.com/show/3LFKY3jlU2T0MpvKwkvMvl?si=acca1fa9413a4f60&nd=1 Subscribe to The Fellow on Call on Google Podcasts: https://podcasts.google.com/search/the%20fellow%20on%20call

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related